UCLA study finds oxaloacetate supplement helps breast cancer survivors

Survivors show cognitive gains after taking supplement

Women who took an oxaloacetate supplement for eight weeks reported substantial improvements in their mental clarity. The trial measured changes in memory, concentration, and fatigue levels among breast cancer survivors. Participants also performed better on tests requiring planning and attention during the study period. These results were published in the journal JCO Oncology Advances by the UCLA team.

Study explains causes of lingering brain fog

About 15 percent to 25 percent of survivors experience ongoing problems with thinking abilities after treatment ends. Scientists note that cancer itself and chemotherapy can disrupt glutamate signaling between nerve cells. Inflammation linked to the disease may also disturb how brain cells produce and use energy efficiently. Dr Patricia Ganz stated that effective treatments for these symptoms remain very limited today.

Larger trials needed to confirm findings

The current clinical trial involved a small group of women who received the naturally occurring molecule. Oxaloacetate plays an important role in how cells generate energy within the human body. Researchers say larger studies are required to fully confirm these promising early evidence results.